<DOC>
	<DOCNO>NCT00251966</DOCNO>
	<brief_summary>The purpose study evaluate effect esomeprazole 20 mg od versus placebo prevention gastric and/or duodenal ulcer patient take low-dose ASA .</brief_summary>
	<brief_title>ASTERIX : Low Dose ASA Nexium</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>A clinical diagnosis condition ( cardiovascular and/or cerebrovascular protection reason ) require daily intake lowdose ASA , 75325 mg , expect continue duration study ( daily define least 5 day per week ) . Age &gt; = 60 year . No gastric and/or duodenal ulcer baseline endoscopy . H. pylori negative serology test screening . Upper GI symptom Erosive oesophagitis Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Prevention gastroduodenal lesion</keyword>
	<keyword>erosive oesophagitis</keyword>
	<keyword>upper GI symptom</keyword>
</DOC>